Latest 10-Q quarterly reports

Xtant Medical Holdings, Inc. reported a significant decrease in revenue for the second quarter of 2026, primarily due to divestitures and the loss of license revenue, alongside a substantial operating expense write-off.

Aura Biosciences reports increased R&D and G&A expenses in Q2 2026, announces a 20% workforce reduction to focus on ocular oncology, and highlights progress in bel-sar clinical trials.

Tango Therapeutics announced promising efficacy data for its vopimetostat combination therapy in pancreatic cancer, alongside significant increases in R&D spending and continued net losses, highlighting ongoing capital requirements.

Kardigan, Inc. details advancements in its cardiovascular drug pipeline, successful IPO, and robust cash position, while acknowledging ongoing development risks.

Upstream Bio, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing ongoing clinical trial progress for its lead candidate, verekitug, while reporting continued net losses and a substantial accumulated deficit.

Vestis Corporation's Q3 2026 results show a significant increase in operating income and net income, driven by successful cost-saving measures and operational efficiencies, despite a marginal decrease in revenue.

NeurAxis, Inc. announced a significant increase in net sales and gross profit for the second quarter of 2026, driven by expanded insurance coverage for its IB-Stim device.

Chicago Atlantic Real Estate Finance reported a decrease in net income and net interest income for Q2 2026, alongside a substantial rise in credit loss provisions, while progressing with its merger with Chicago Atlantic BDC, Inc.

Immunic, Inc. (IMUX) filed its Form 10-Q for the quarter ended June 30, 2026, detailing ongoing clinical development for its lead multiple sclerosis drug candidate, vidofludimus calcium, while reporting increased operating expenses and a net loss.

Shattuck Labs, Inc. (STTK) announced positive Phase 1 data for its lead candidate SL-325, demonstrating a favorable safety profile and complete receptor occupancy, while also reporting increased cash reserves from recent financings.

Twenty One Capital, Inc. filed its Q2 2026 Form 10-Q, detailing a substantial net loss driven by a significant decrease in the fair value of its Bitcoin holdings, alongside changes in executive leadership.

Ampco-Pittsburgh Corporation's Q2 2026 filing shows a significant improvement in operating income driven by the Air and Liquid Processing segment, alongside a growing backlog, despite a dip in net sales.

DarioHealth Corp. announced its second-quarter 2026 financial results, showing a decrease in total revenues and a continued net loss, though operating expenses were reduced.

Scientist Home Future Health Limited reported increased revenues for the six months ended June 30, 2026, but also significant net losses and a substantial decrease in cash, raising going concern doubts.

Team, Inc. announced its Q2 2026 financial results, reporting a net loss of $6.812 million on revenues of $228.678 million, a decrease from the prior year.

Oramed Pharmaceuticals Inc. filed its Form 10-Q for the period ended June 30, 2026, reporting substantial financial income driven by investment revaluations, alongside an operating loss.

Surf Air Mobility Inc. reported increased revenue in its Q2 2026 filing, driven by its on-demand charter business, but continues to grapple with significant operating losses, tax defaults, and a going concern warning.

FirstSun Capital Bancorp reported a net loss of $22.9 million for Q2 2026, a significant shift from the prior year's profit, largely impacted by acquisition-related expenses and increased credit loss provisions.

Investors Title Company's Q2 2026 results show a significant increase in net premiums written and net income, driven by higher real estate activity and expansion initiatives.

BTC Development Corp. reports on its financial condition for the quarter ended June 30, 2026, highlighting interest income from its trust account while continuing its search for a business combination.

Microvast Holdings, Inc. reported a significant revenue decline for the six months ended June 30, 2026, and continues to face substantial doubt regarding its ability to continue as a going concern.

American Rebel Holdings, Inc. reported a significant net loss for the second quarter of 2026, with revenues declining by 30% year-over-year, alongside increased operating expenses and continued liquidity concerns.

Sound Financial Bancorp, Inc. announced its second quarter 2026 financial results, showing a 22.7% increase in net income driven by growth in net interest income and a favorable shift in the provision for credit losses.

Green Dot Corporation reported an 18.2% increase in total operating revenues for Q2 2026, driven by strong B2B services growth, though consumer services saw a 9% decline.

i-80 Gold Corp. reports substantial progress in its financing and development plans for the quarter ended June 30, 2026, including significant capital raises and advancements at key projects, despite continued operational costs and net losses.

Pangaea Logistics Solutions Ltd. announced a substantial increase in revenue and net income for the second quarter of 2026 compared to the prior year, driven by improved freight rates and operational efficiencies.

Csquare, Inc. reported a 15% increase in revenue for the six months ended June 30, 2026, to $550.8 million, but also a significant widening of its net loss to $114.8 million.

Hallador Energy Company reported a net loss for the second quarter of 2026, impacted by increased operating expenses and significant capital commitments for a major turbine equipment acquisition.

HF Foods Group Inc. announced its second quarter 2026 financial results, showcasing a 2.8% increase in net revenue to $323.8 million and a significant rise in net income attributable to the company to $2.6 million.

WhiteHorse Finance reports on its Q2 2026 financial performance, detailing portfolio shifts, stable investment yields, and ongoing credit facility management.